A detailed history of Alphabet Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 241,264 shares of VERA stock, worth $10.2 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
241,264
Previous 241,264 -0.0%
Holding current value
$10.2 Million
Previous $8.73 Million 22.15%
% of portfolio
0.73%
Previous 0.55%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$14.91 - $49.14 $899,311 - $2.96 Million
-60,316 Reduced 20.0%
241,264 $10.4 Million
Q1 2022

Nov 14, 2022

SELL
$17.8 - $28.06 $7.33 Million - $11.6 Million
-412,078 Reduced 57.74%
301,580 $7.08 Million
Q4 2021

Nov 14, 2022

SELL
$15.01 - $35.8 $3.47 Million - $8.27 Million
-231,133 Reduced 24.46%
713,658 $19.1 Million
Q2 2021

Nov 14, 2022

BUY
$11.5 - $19.97 $10.9 Million - $18.9 Million
944,791 New
944,791 $12.5 Million

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.15B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Alphabet Inc. Portfolio

Follow Alphabet Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.